ReviewAdvances and technical standards in neurosurgery2026
The Pinealoprive Syndrome: Myth or Reality?
Review in Advances and technical standards in neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although the role of melatonin in many biological functions, foremost among them the regulation of circadian rhythms and sleep, has been widely demonstrated, the definition of a specific disorder linked to melatonin deficiency remains debated. As the main function of the pineal gland is to secrete melatonin, pineal lesions and pinealectomy provide insightful models for understanding the effect of acute and chronic suppression of melatonin secretion ("pinealoprive syndrome"). In pineal parenchymal cell tumor, melatonin levels are usually normal/high, whereas impaired secretion is thought to reflect parenchymal destruction and thus tumors with malignant profiles. Following pinealectomy, low or undetectable levels of melatonin are observed, suggesting that melatonin assay may be used to monitor complete tumoral and pineal gland resection. However, the link between melatonin depletion in this context and the objective/subjective quality of sleep remains unclear. Likewise, while melatonin is involved in a large number of physiological functions, damage to the pineal gland does not appear to have any clear extra-neurological effects. This paradox might be explained by the presence of extra-pineal melatonin secretion sites. In addition, it is possible that the effects of melatonin depletion are long term, in real-life situations, and fluctuate according to the season. Importantly, most evidence relies on very small samples due to the rarity of pineal gland lesions. Further prospective longitudinal studies on wider cohorts are needed, to definitively conclude on the impact of pineal gland-related melatonin on health in general and sleep in particular. There is therefore no recommendation for melatonin supplementation after pinealectomy. Pragmatically, in the presence of melatonin deficiency and sleep disorders in the context of pineal gland tumor/pinealectomy, and given the safety of melatonin as a medication, it seems reasonable to propose exogenous melatonin, with a chronobiotic or sedative purpose depending on the type of disorder.
Indexed as
Identifiers
42115467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.